<DOC>
	<DOCNO>NCT01031121</DOCNO>
	<brief_summary>Background : - Self-report biochemical verification use determine smoke status treatment trial clinical research . Each method merit limitation make appropriate particular situation . Participants feel social pressure report tobacco abstinence may provide unreliable self-reporting result . Biochemical verification use breath carbon monoxide ( CO ) reliable indicator , several biological environmental factor ( include exposure secondhand smoke ) affect sensitivity specificity breath CO measurement . - An ideal biomarker smoking status cotinine , major metabolite nicotine . Cotinine level find blood , urine , saliva use distinguish smoker nonsmoker , well light heavy smoker . Researchers interested use cotinine assessment develop suitable breath CO cutoff level categorize different type smoker nonsmoker use future research . Objectives : - To determine breath carbon monoxide ( CO ) cutoff level optimally discriminate heavy light smoker nonsmoker expose environmental tobacco smoke . Eligibility : - Individuals 18 64 year age fall one follow group : - current smoker report 10 cigarette per day least 6 month - current smoker report 10 few cigarette per day least 6 month - nonsmoker report regular environmental exposure tobacco smoke - nonsmoker report limited exposure tobacco smoke Design : - The study involve single outpatient session . - Participants provide breath CO , urine , saliva sample , complete several smoking-related questionnaire smoke history , current craving level , perceive level nicotine dependence .</brief_summary>
	<brief_title>Breath Carbon Monoxide Cotinine Biomarkers Distinguish Smokers From Nonsmokers</brief_title>
	<detailed_description>Objective : To determine breath carbon monoxide ( CO ) cutoff level optimally discriminate heavy light smoker nonsmoker expose environmental tobacco smoke . Breath CO compare cotinine concentration , gold standard verify smoking status . Study population : The study include four group : 1 ) 60 smoker report &gt; 10 cigarette per day , 2 ) 60 smoker report less equal 10 cigarette per day , 3 ) 60 nonsmoker report regular environmental exposure tobacco smoke , 4 ) 60 nonsmoker report limited environmental exposure tobacco smoke ( total 120 smoker 120 nonsmoker ) . Design : Parallel group design . Outcome Measures : 1 ) breath CO ; 2 ) semiquantitative salivary cotinine ; 3 ) quantitative salivary nicotine , cotinine , 3-hydroxycotinine ; 4 ) semiquantitative urinary cotinine ; 5 ) quantitative urinary nicotine , cotinine , norcotinine , 3-hydroxycotinine ; 6 ) self-reported smoking variable .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Carbon Monoxide</mesh_term>
	<criteria>INCLUSION CRITERIA : For Smokers : 1. male female 1864 year old 2. smoking 110 cigarette &gt; 10 cigarette per day past 6 month For Nonsmokers : 1. male female 1864 year old EXCLUSION CRITERIA : For Smokers : 1. current interest reduce quit smoke 2. treatment nicotine dependence past 3 month 3. use nicotine replacement product , bupropion , varenicline past 3 month 4. current use tobacco product cigarettes 5. marijuana use great 5 time past 14 day use 24 hour session 6. chronic pulmonary disease 7. study investigator subordinate staff For Nonsmokers : 1. use tobacco nicotine product past 3 month 2. marijuana use great 5 time past 14 day use 24 hour session 3. chronic pulmonary disease 4. study investigator subordinate staff</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 22, 2010</verification_date>
	<keyword>Cigarette Smoking</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Cotinine</keyword>
	<keyword>Metabolites</keyword>
</DOC>